Professor, Department of Hematology & Oncology, Samsung Medical Center

Speciality Interests

Lung cancer, Head and neck cancer

Schedule

schedule of week
04 MON
22
TUE
23
WEN
24
THU
25
FRI
26
AM available available
PM available

Medical School

2010~2012 Ph.D. in Medicine Graduate School, Hanyang University, Seoul, KOREA 2004~2007 Master of Science Graduate School, Hanyang University, Seoul, KOREA 1981~1985 M.D. College of Medicine, Hanyang University, Seoul, KOREA 1979~1981 Premedicine College of Natural Science, Hanyang University, Seoul, KOREA

Specialty Training

Specialty Training
Fellowship   1993~1995 Postdoctoral Fellowship Memorial Sloan-Kettering Cancer Center, New York, U.S.A
1991~1993 Hematology-Oncology, Asan Medical Center Univesity of Ulsan, Seoul, KOREA
Residency   1986~1989 Internal Medicine, Hanyang University Hospital, Seoul, KOREA
Internship   1985~1986 Medicine, Hanyang University Hospital, Seoul, KOREA

Other Education

  • 2006~Present Professor Division of Hematology-oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    2005~2006 Professor "Division of Hematology-Oncology, Department of Medicine, Hanyang University Hospital, Seoul, KOREA
    2000~2004 Associate Professor Division of Hematology-Oncology, Department of Medicine, Hanyang University Hospital, Seoul, KOREA
    1995~1999 Assistant Professor Division of Hematology-Oncology, Department of Medicine, Hanyang University KURI Hospital, Kyunggi-do, KOREA

Participation in Academic Societies
and Research

  • Present Member Korean Medical Association
    Present Member Korean Association of Internal Medicine
    Present Member Korean Association of Cancer
    Present Member Korean Society of Medical Oncology
    Present Member Korean Association for Lung Cancer
    Present Member American Association for Cancer Research
    Present Member American Society of Clinical Oncology
    Present Member International Association for the Study of Lung Cancer
    Present Member European Society of Medical Oncology
    Present Member Korean Cancer Study Group

Thesis

ESMO OPEN 2021 10.1016/j.esmoop.2021.100113

Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours

Paz-Ares1, L; Barlesi, F; Siena, S; Ahn, MJ; Drilon, A; Conley, A; Rolfo, C; Wolf, J; Seto, T; Doebele, R; Kapre, A; Chen, D; McCallum, S; Osborne, S; Demetri, G

PROCESSES 2021 10.3390/pr9050792

Comprehensive Analysis of Mutation-Based and Expressed Genes-Based Pathways in Head and Neck Squamous Cell Carcinoma

Keam1, B; Park, JY; Kim, JP; Kim, GD; Yu, YS; Cho, SH; Kim, S; Ahn, HK; Chun, SH; Kwon, JH; Yun, T; Kim, JW; Kim, JE; Ahn, MJ; Kim, JH; Yun, HJ

J THORAC ONCOL 2021 10.1016/j.jtho.2020.12.002

Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations

Passaro1, A; Mok, T; Peters, S; Popat, S; Ahn, MJ; de Marinis, F

J CLIN ONCOL 2021 10.1200/JCO.20.03025

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer

Dziadziuszko1, R; Krebs, MG; De Braud, F; Siena, S; Drilon, A; Doebele, RC; Patel, MR; Cho, BC; Liu, SV; Ahn, MJ; Chiu, CH; Farago, AF; Lin, CC; Karapetis, CS; Li, YC; Day, Bm; Chen, D; Wilson, TR; Barlesi, F

CANCER 2021 10.1002/cncr.33571

High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean lung liquid versus invasive biopsy program

Park1, S; Olsen, S; Ku, BM; Lee, MS; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Choi, YL; Ahn, MJ

CLOSE

Patients' Rights and Responsibilities

Patients' Rights

1. Right to receive medical care

Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

2. Right to be informed and to make an autonomous decision

Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

3. Right to confidentiality

Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

4. Right to request consultation and mediation

In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

5. Right to have values and beliefs respected

Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

6. Right to receive care in a safe setting

Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

Patients' Responsibilities

1. Responsibility to trust and respect the medical team

Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

2. Responsibility to not use dishonest methods for medical treatment

Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

3. Responsibility to abide by all hospital regulations

Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.